XML 35 R16.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity
3 Months Ended
Jan. 31, 2022
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Analysis of Changes in Accumulated Other Comprehensive (Loss) Income:
(In millions)Foreign Currency Translation AdjustmentMinimum Pension LiabilityDerivative InstrumentsTotal
Balance at October 31, 2020$(402.3)$(56.7)$(13.0)$(472.0)
Gross change in value82.2 29.8 34.3 146.3 
Tax effect(0.2)(7.2)(8.2)(15.6)
Balance at October 31, 2021$(320.3)$(34.1)$13.1 $(341.3)
Gross change in value(49.2)— 17.6 (31.6)
Tax effect— — (4.3)(4.3)
Balance at January 31, 2022$(369.5)$(34.1)$26.4 $(377.2)
Share Repurchases
In December 2011, the Company's Board of Directors authorized the 2012 Share Repurchase Program and through subsequent amendments, the most recent in March 2017, the total repurchase authorization was increased from $500.0 million to $1.0 billion of the Company's common stock. This program has no expiration date and may be discontinued at any time. Purchases under the 2012 Share Repurchase Program are subject to a review of the circumstances in place at the time and may be made from time to time as permitted by securities laws and other legal requirements.
During the first quarter of fiscal 2022, the Company repurchased 191.2 thousand shares of the Company’s common stock for $78.5 million, at an average purchase price of $410.41 per share. At January 31, 2022, $256.4 million remained authorized for repurchase under the program.
During the first quarter of fiscal 2021, the Company repurchased 69.6 thousand shares of the Company’s common stock for $24.8 million, at an average purchase price of $356.61 per share.
Dividends
The Company paid a semiannual dividend of approximately $1.5 million or 3 cents per share, on February 9, 2022, to stockholders of record on January 21, 2022.